Fig. 7 | Scientific Reports

Fig. 7

From: Molecular subtyping of renal clear cell carcinoma based on prognostic RASSF family genes and validation of C1QL1 as a key prognostic marker

Fig. 7

Characteristics of chemotherapy, targeted therapy, and immunotherapy in high and low scores. (A) Survival curve of patients with high and low scores. (B–D) Response to cisplatin, gemcitabine, and pazotinib in patients with high scores. (E–F) Treatment sensitivity of patients with high scores to sorafenib and axitinib. (G–H) Response to mTOR in patients with high scores. (I–L) Expression of common immunoassays LAG3, PDCD1, CTLA4, and CD274 in patients with high scores. (M–N) Relationship between high CTLAT4 and PDL1 expression and IPS in patients with high score. (O–R) Differences in PD1 immunotherapy response in patients with high scores.

Back to article page